
Opinion|Videos|December 21, 2023
Treatment Approaches for Early-Stage Lung Cancer
Author(s)Patrick Forde, MBBCh
Patrick Forde, MBBCh offers an overview of current standard-of-care treatments as well as emerging immunotherapy options for treating early-stage, resectable non-small cell lung cancer.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
2
Lisaftoclax Monotherapy Achieves Significant Responses and PFS in R/R CLL/SLL
3
Earlier Cilta-Cel Improves Myeloma Outcomes Via Enhanced Immune Fitness
4
Odronextamab Plus CHOP Shows Promise in Early Phase 3 Data for Untreated DLBCL
5








































